Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.93
0.13 (2.71%)
At close: Oct 16, 2025, 3:59 PM
4.93
0.00%
After-hours: Oct 16, 2025, 07:49 PM EDT
2.71% (1D)
Bid | 4.7 |
Market Cap | 87.07M |
Revenue (ttm) | 568K |
Net Income (ttm) | -31.5M |
EPS (ttm) | -2.74 |
PE Ratio (ttm) | -1.8 |
Forward PE | 0.43 |
Analyst | Buy |
Dividends | n/a |
Ask | 5.2 |
Volume | 802,026 |
Avg. Volume (20D) | 438,912 |
Open | 4.84 |
Previous Close | 4.80 |
Day's Range | 4.84 - 5.34 |
52-Week Range | 3.71 - 11.00 |
Beta | 1.86 |
Ex-Dividend Date | n/a |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsUnicycive Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-29.85%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
-8.89%
Unicycive Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split effective June 20, 2025.

3 weeks ago · businesswire.com
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCYLOS ANGELES--(BUSINESS WIRE)--Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY.